Literature DB >> 28440203

Antimicrobial, Biofilm Inhibitory and Anti-infective Activity of Metallic Nanoparticles Against Pathogens MRSA and Pseudomonas aeruginosa PA01.

Jamuna B Aswathanarayan1, Ravishankar R Vittal1.   

Abstract

BACKGROUND: The emergence of drug resistant pathogens is a major concern to the scientific community. Novel approaches such as the use of functionalized nanomaterials with antimicrobial activity is required to treat infectious diseases.
OBJECTIVE: In the present study, the metallic nanoparticles (iron, gold, zinc oxide and copper oxide) were evaluated for the antimicrobial, biofilm inhibitory and anti-infective activity against human pathogens methicillin resistant Staphylococcus aureus and Pseudomonas aeruginosa PA01.
METHODS: The efficacy of nanoparticles on the planktonic growth of clinically relevant pathogens was determined by MIC. Further, the effect of nanoparticles was studied on their biofilms using crystal violet microtiter plate assay and fluorescent microscopy. The cytotoxicity of nanoparticles was studied in HT29 cell line.
RESULTS: The nanoparticles of copper and zinc oxide (size < 50 nm) were more effective against Grampositive and Gram-negative pathogens in comparison to gold and iron nanoparticles. The ZnO nanoparticles had an MIC in the range of 3.125 μg/ ml and 6.25 μg/ ml against the tested pathogens. The nanoparticles at the tested concentration reduced biofilm burden by > 75% in the pathogens. The nanoparticles showed cytotoxicity in HT 29 at 20 μg/ ml.
CONCLUSION: The results of the study showed that of all the tested nanoparticles, ZnO nanoparticles had significant antimicrobial activity against the drug resistant pathogens and could be used at concentrations less toxic to mammalian cells. Hence, ZnO nanoparticles have the potential for the design of novel antibacterial agents and therapeutics. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Anti-infective; MRSA; Pseudomonas aeruginosa PA01; Zinc oxide nanoparticles; antimicrobial; biofilm inhibitory

Mesh:

Substances:

Year:  2017        PMID: 28440203     DOI: 10.2174/2211738505666170424121944

Source DB:  PubMed          Journal:  Pharm Nanotechnol        ISSN: 2211-7385


  7 in total

Review 1.  Nanoparticles for treatment of bovine Staphylococcus aureus mastitis.

Authors:  Samah Attia Algharib; Ali Dawood; Shuyu Xie
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

2.  Label-free cell based impedance measurements of ZnO nanoparticles-human lung cell interaction: a comparison with MTT, NR, Trypan blue and cloning efficiency assays.

Authors:  Giuseppina Bozzuto; Giuseppe D'Avenio; Maria Condello; Simona Sennato; Ezio Battaglione; Giuseppe Familiari; Agnese Molinari; Mauro Grigioni
Journal:  J Nanobiotechnology       Date:  2021-10-07       Impact factor: 10.435

Review 3.  From Copper Tolerance to Resistance in Pseudomonas aeruginosa towards Patho-Adaptation and Hospital Success.

Authors:  Maxine Virieux-Petit; Florence Hammer-Dedet; Fabien Aujoulat; Estelle Jumas-Bilak; Sara Romano-Bertrand
Journal:  Genes (Basel)       Date:  2022-02-04       Impact factor: 4.096

Review 4.  Emerging Nanomedicine Therapies to Counter the Rise of Methicillin-Resistant Staphylococcus aureus.

Authors:  Alan Hibbitts; Cian O'Leary
Journal:  Materials (Basel)       Date:  2018-02-23       Impact factor: 3.623

Review 5.  Nano-Strategies to Fight Multidrug Resistant Bacteria-"A Battle of the Titans".

Authors:  Pedro V Baptista; Matthew P McCusker; Andreia Carvalho; Daniela A Ferreira; Niamh M Mohan; Marta Martins; Alexandra R Fernandes
Journal:  Front Microbiol       Date:  2018-07-02       Impact factor: 5.640

Review 6.  Nanomaterials as Delivery Vehicles and Components of New Strategies to Combat Bacterial Infections: Advantages and Limitations.

Authors:  Atanu Naskar; Kwang-Sun Kim
Journal:  Microorganisms       Date:  2019-09-16

Review 7.  Emerging Strategies to Combat β-Lactamase Producing ESKAPE Pathogens.

Authors:  Corneliu Ovidiu Vrancianu; Irina Gheorghe; Elena-Georgiana Dobre; Ilda Czobor Barbu; Roxana Elena Cristian; Marcela Popa; Sang Hee Lee; Carmen Limban; Ilinca Margareta Vlad; Mariana Carmen Chifiriuc
Journal:  Int J Mol Sci       Date:  2020-11-12       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.